PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Linezolid - Mild to moderate skin and soft tissue infections
PAD Profile : Linezolid - Mild to moderate skin and soft tissue infections
Keywords :
antibiotic, antibacterial
Brand Names Include :
Zyvox
Traffic Light Status
Status 1 of 1.
Status :
Green
Important
Formulations :
- Oral suspension
- Tablets
Important Information :
Committee were asked to consider the issues associated with the prescribing of linezolid in primary care for mild to moderate skin/soft tissue infections (SSTIs) in patients: Linezolid prescribing for mild to moderate SSTI in line with HPA recommendations is an option for primary care prescribing especially where referral/admission to secondary care is to be avoided. Primary/secondary care interface: Treatment courses that are initiated in secondary care should be supplied by the Trust in their entirety. GPs should not be asked to prescribe the remainder of linezolid courses. Shared care is therefore not considered appropriate for this drug.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
Additional Documents
Type
Document
Review Date
Guidelines (Local)
01 April 2015
Committee Recommendations
Date
Committee Name
Narrative
22 February 2012
Surrey Medicines Commissioners Group
Committee were asked to consider the issues associated with the prescribing of linezolid in primary care for mild to moderate skin/soft tissue infections (SSTIs) in patients: Linezolid prescribing for mild to moderate SSTI in line with HPA recommendations is an option for primary care prescribing especially where referral/admission to secondary care is to be avoided. Primary/secondary care interface: Treatment courses that are initiated in secondary care should be supplied by the Trust in their entirety. GPs should not be asked to prescribe the remainder of linezolid courses. Shared care is therefore not considered appropriate for this drug. Information sheet [linezolid]to support GPs to be developed.
Associated BNF Codes
05. Infections
05.01.07. Some other antibacterials